@DamianFierce: Covance took a $12.7M loss in the second quarter, but analysts are still optimistic about the company's future. More | Follow @DamianFierce
> Outcome-based payment for CROs may be the future of the industry, according to one strategic outsourcing firm. News
> AstraZeneca ($AZN) has signed on to use Assay Depot, an Internet database that unites pharmas and contractors. Article
> Cleveland's ImageIQ has secured a contract with Histogenics to provide imaging analytics for a Phase II trial of the company's NeoCart implant. More
> Clinical trials conducted by drugmakers may be biased, a federal group says, as companies sometimes deliberately compare new treatments to inferior drugs. Story
> GVK Biosciences has cleared an FDA audit of its Ahmedabad Clinical Pharmacology Unit, a 110-bed facility in India. Release